pfc-icci-8-kopie

ICCI Presents the University of Chemistry and Technology in Prague (UCHT) with the first Patient Focused Certification (PFC) verification outside the US

(Prague, 14 November 2016) Today the first official certificate of the Patient Focused Certification (PFC) given outside the United States was presented to the University of Chemistry and Technology in Prague. The certification was received at a press conference at the University, led by global awarded Professor Jana Hajšlová. PFC U.S. leaders Dr. Jahan Marcu and Kristin Nevedal are in Czech Republic on behalf of ICCI to train European PFC auditors, cultivators and manufacturers of medical cannabis and hemp and to audit Czech companies.

The PFC program is a peer reviewed, third party certification program for the cannabis industry and the only European certification program that uses AHPA* and HP** standards.

“The hemp industry is growing significantly every year and like other sectors of industry, is in need of standards to ensure safe production,” says Hana Gabrielová, PFC Director for Europe. The licensing and localization of PFC in Europe is a result of cooperation between the International Cannabis and Cannabinoids Institute (ICCI) and Americans for Safe Access (ASA).

Launched in the United States in 2013, to address issues of quality control and product safety in the cannabis industry and to ensure that patients (consumers), healthcare providers and governments can rely on high-quality cannabis products. PFC represents the consensus of the world’s leading experts on cannabis, hemp and botanical product regulations and it guidelines have been adopted in 16 states in the US.

PFC establishes quality standards in cannabis cultivation, production, distribution and laboratory analyzes, and also includes employee training and educational materials. PFC helps to define the processes, procedures and materials to ensure that hemp products have specific qualitative and quantitative composition, are free of harmful substances, and have their own unique identity, so they can be identified if necessary at the retail market.

The certification ceremony will be attended by Professor Jana Hajšlová who was very happy that her lab at the VSCHT has been certified as the first outside the US and globally X. lab: “I am glad that another important independent institution appreciated our excellence in the field of consumer protection and chemical-analytical methods of quality control of products for human consumption.”

“Today is an important day for consumers using hemp products in Europe. Demand for natural, quality products is worldwide and the PFC program will help ensure that consumers are protected and satisfied” says Steph Sherer, founder and director of ASA, the largest medical cannabis patient advocacy organization in the United States.

“We are very pleased that the first laboratory outside of the United States  to receive  the certification is led by Professor Jana Hajšlová,” says CEO of the ICCI Pavel Kubu. “This is another extension of long-term collaboration between ICCI and the VSCHT and confirms the Czech Republic’s role as a global leader in this very promising area of research and development,” he adds.

ICCI was established as a joint venture project of patient organizations, scientific societies and investment company Dioscorides Global Holdings. Its headquarter is based in  Prague and as a center of excellence cooperates with the Charles University in Prague, Hebrew University of Jerusalem, Masaryk University in Brno, Mendel University in Brno, Czech Technical University in Prague, Czech University of Life Science in Prague.

You can see video trailer from the conference HERE